Hunan Hansen Pharmaceutical Co.,Ltd.



Quote for Hunan Hansen Pharmaceutical Co.,Ltd.

Last Trade:
-
Change:
--
Symbol/Code:
002412
Status:
-
Stock Type:
A Share
Market Cap:
-
Open:
-
Prev Close:
-
Bid:
-
Ask:
-
Volume(*100):
-
Amount:
-
Limit Up:
-
Limit Down:
-
Day's Range:
-
P/E(ttm):
-
P/B ratio
-
Update:-
Currency in CNY Time=UTC+8002412 quote

Summary for Hunan Hansen Pharmaceutical Co.,Ltd.

Hunan Hansen Pharmaceutical Co., Ltd is principally engaged in the research, development, production and distribution of Chinese traditional medicines, which used for gastrointestinal disease, orthopedic traumatism disease and cardiovascular and cerebrovascular disease, among others. The Company primarily provides tablets, capsules, granules, pills, soft extracts, syrup, oral liquids, tincture, large-volume injections, small-volume injections, psychotropic substances, as well as bulk drugs, among others. The Company's main products include Simotang oral liquid, used for abdominal distention and phlegmatic abdominalgia; Yushangling capsules, used for injuries from falls; Yinxingye capsules, used for stroke and chest distress, as well as Suoquan capsules, used for kidney deficiency, among others. The Company mainly distributes its products in domestic markets.

Profile for Hunan Hansen Pharmaceutical Co.,Ltd.

Full Name:Hunan Hansen Pharmaceutical Co.,Ltd.
Full Name in Chinese:湖南汉森制药股份有限公司 Short Name in Chinese:汉森制药
Symbol/Stock Code:
002412
Listed in:
Shenzhen Stock Exchange
Issued Capital
-
Negotiable Capital:
-
Chairman:
Liu Lingan
Secretary of the Board:
Liu Houyao
Phone:
+86-737-6351486
Fax:
+86-737-6351067
Official Website:www.hansenzy.com
E-mail:office@hansenzy.com
Address:Longling Industrial Park,Yincheng South Road,YIYANG HUN 413000
IPO Subscription Date:
2010-05-11
Listing Date:
2010-05-25
IPO Issued Capital:
19000000
IPO Price:
35.8 CNY
IPO fees:
31716500 CNY
Money Raised by IPO:
680200000 CNY
IPO Par Value:
1.00 CNY
Net Money Raised:
648483500 CNY
Open(Listing day):
42.33 CNY
Close(Listing day):
43.17 CNY
Diluted P/E ratio after IPO:
55.0800
Turnover rate(listing day):
79.26%

Financials for Hunan Hansen Pharmaceutical Co.,Ltd.

UPDATE:2012-10-24 Annual Report Abstract:(All Currency In CNY)

Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Net Profit(after tax)(Million)
59.0345
58.827
62.0212
49.2502
Net Profit Growth(%)
26.74
-5.15
25.93
15.89
Return On Equity(ROE)(%)
6.26
6.66
6.90
27.44
Debt ratio(%)
10.18
5.85
5.19
27.38
Net Operating Cash Flow/Net Profit(%)
145.06
91.52
34.25
83.28

Per Share Financial Data:(All Currency In CNY)

Per Share Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Earnings Per Share(EPS)
0.4000
0.4000
0.4700
0.9000
Diluted Earnings Per Share
0.0000
0.3900
0.4900
0.8800
Net Asset Value Per Share (NAVPS)
6.3700
5.9700
12.1500
3.2600
Additional Paid-In Capital Per Share
3.9897
3.9897
8.9794
0.4761
Retained Earnings Per Share
1.2334
0.8346
1.9904
1.6518
Net Cash Flow From Operatings Activities Per Share
0.5800
0.3600
0.2900
0.7500
Net Cash Flow Per Share
1.2044
-0.0309
0.5106
0.0776

Balance Sheet:(All Currency In CNY)

Assets And Liabilities/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Total Assets(Million)
1049.558
938.5963
948.0531
247.1963
Total Liabilities(Million)
106.873
54.9457
49.2295
67.6863
Current Liabilities(Million)
103.3817
52.819
46.8517
67.3363
Long Term Liabilities(Million)
-
-
-
-
Cash And Cash Equivalents(Million)
658.7697
642.5199
695.0954
57.3111
Accounts Receivables(Million)
87.2889
62.8735
50.5127
41.6503
Deposit Received(Million)
1.4575
2.4619
4.5315
2.2149
Other Receivables(Million)
0.9072
0.4771
8.4111
12.828
Bad Debt Reserve(Million)
-
-
-
-
Shareholder's Equity/Owner's Equity(Million)
942.685
883.6506
898.8235
179.51
Debt ratio(%)
10.18
5.85
5.19
27.38
Equity Ratio(%)
89.8100
94.1400
94.8000
72.6100
Current Ratio
8.5515
15.7385
18.4253
2.4497
Quick Ratio
8.3097
15.2785
18.0962
2.2362

Cash Flow Statement:(All Currency In CNY)

Cash Flow/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Cash From Selling Commodities(Million)
408.0958
477.0307
346.7369
312.1641
Net Cash Flow From Operatings Activities(Million)
85.636
53.8408
21.2407
41.0171
Net Cash Flow From Operatings Activities Change(%)
188.88
153.48
-48.22
20.86
Net Cash Flow(Million)
178.2498
-4.5755
37.7842
4.2683
Cash From Selling Commodities/Prime Revenue(%)
113.15
119.02
100.97
110.22
Net Cash Flow/Net Profit(%)
301.94
-7.78
60.92
8.67
Cash Flow From Investing Activities(Million)
92.0438
15.2167
-603.5715
-20.5015
Cash Flow From Financing Activities(Million)
0.5701
-73.6329
620.115
-16.2472

Income Statement:(All Currency In CNY)

Income Indicators/Till The Date
2012-09-30
2011-12-31
2010-12-31
2009-12-31
Prime Operating Revenue(Million)
360.656
400.786
343.4155
283.2114
Prime Operating Profit(Million)
-
-
-
-
Operating Costs(Million)
186.9468
217.3905
164.8127
129.3033
Administrative Costs(Million)
19.3787
26.1541
33.6808
19.9834
Financing Costs(Million)
-11.9718
-14.1683
-8.774
3.1389
Above Three Costs Change(%)
28.80
20.90
24.47
23.30
Operating Profit(Million)
68.248
68.5927
66.8222
58.538
Income From Investment(Million)
-
-
-
-
Government Subsidies(Million)
-
-
-
-
Net Non-Operating Income And Expense(Million)
1.3753
0.9524
6.2672
1.0387
Total Profit(Million)
69.6233
69.5451
73.0894
59.5766
Corporate Income Tax(Million)
10.5889
10.718
11.0683
10.3264
Net Profit(Million)
59.0345
58.827
62.0212
49.2502
Gross Profit Ratio(%)
74.91
76.00
76.51
76.24
Operating Margin(%)
18.92
17.11
19.45
20.66
Return On Equity(ROE)(%)
6.26
6.66
6.90
27.44

Announcements for Hunan Hansen Pharmaceutical Co.,Ltd.

Date: 2012-08-21
Title: EGM RESOLUTION
The Company held its 1st Extraordinary General Meeting of 2012 on 20 August 2012, during which the following proposal(s) was/were approved:
1. Amendments to the Company's articles of association
2. Appointment of Liu Naxin as independent director candidate
3. Dividend management system
4. Plan on the shareholders' return for the next three years from 2012 to 2014
Date: 2012-08-01
Title: EGM-SPOT
The Company will hold the 1st Extraordinary General Meeting of 2012 at 15:00 on 20 August 2012.

Meeting agenda:
1. Amendments to the Company's articles of association
2. Appointment of Liu Naxin as independent director candidate
3. Dividend management system
4. Plan on the shareholders' return for the next three years from 2012 to 2014


Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 15 August 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: 17 August 2012
Date: 2012-05-11
Title: AGM RESOLUTION
The Company held its Annual General Meeting of 2011 on 10 May 2012, during which the following proposal(s) was/were approved:
1. 2011 work report of the board of directors
2. 2011 work report of the supervisory committee
3. 2011 financial resolution report
4. 2011 profit distribution plan
5. 2011 annual report and its summary
6. Dismissal of Mr Chen Shuiqing as vice chairman of the board and director
7. Election of Mr Qiao Zhicheng as director
8. 2012 continuing connected transactions
9. Reappointment of audit firm
The detailed profit distribution plan are as follows:
1) Cash dividend/10 shares (tax included): CNY0.00000000
2) Bonus issue from profit (share/10 shares): none
3) Bonus issue from capital reserve (share/10 shares): none.
Date: 2012-04-12
Title: FINAL DIVIDEND
The Company issued its 2011 annual report on 12 April 2012.

The profit distribution proposal for 2011:
1. Cash dividend/10 shares (tax included): CNY0.00000000
2. Bonus issue from profit (share/10 shares):none
3. Bonus issue from capital reserve (share/10 shares):none.
Date: 2012-04-12
Title: AGM-SPOT
The Company will hold the 2011 Annual General Meeting at 09:00 on 10 May 2012.

Meeting agenda:
1. 2011 work report of the board of directors
2. 2011 work report of the supervisory committee
3. 2011 financial resolution report
4. 2011 profit distribution plan
5. 2011 annual report and its summary
6. Dismissal of Mr Chen Shuiqing as vice chairman of the board and director
7. Election of Mr Qiao Zhicheng as director
8. 2012 continuing connected transactions
9. Reappointment of audit firm
The detailed profit distribution plan are as follows:
1) Cash dividend/10 shares (tax included): CNY0.00000000
2) Bonus issue from profit (share/10 shares): none
3) Bonus issue from capital reserve (share/10 shares): none

Meeting attendees:
1. A-share holders registered at CSDCC Shenzhen after the close of trading on 08 May 2012 are entitled to vote. Original notarized power of attorney for voting is required.
2. Directors of the board, supervisors of the supervisory committee, senior executives and appointed lawyers are entitled to attend the meeting.

Registration period: 09 May 2012
Date: 2011-05-16
Title: DIVIDEND IMPLEMENTATION (CASH AND BONUS ISSUE)
2010 FINAL DISTRIBUTION PLAN TO BE IMPLEMENTED (A SHARES):

1. CASH DIVIDEND/10 SHARES (TAX INCLUDED): CNY10.0000
2. BONUS ISSUE FROM PROFIT (SHARE/10 SHARES): NONE
3. BONUS ISSUE FROM CAPITAL RESERVE (SHARE/10 SHARES): 10.00


RECORD DATE: 20MAY11
EX-DATE: 23MAY11
PAYMENT DATE: 23MAY11
LISTING DATE OF THE BONUS ISSUES: 23MAY11
10 PERCENT WITHHOLDING TAX ON CASH DIVIDEND WILL BE DEDUCTED IN CNY WITHIN THE CASH DIVIDEND RECEIVABLE. PLEASE REFER TO BELOW DETAILS:
TAX ON CASH DIVIDEND/10 SHARES: CNY 1.000000(10 PERCENT X CNY 10.000000)
NET CASH DIVIDEND/10 SHARES AFTER TAX: CNY 9.000000(CNY 10.000000- CNY1.000000)
Date: 2011-04-22
Title: AGM RESOLUTION
THE CO HELD ITS 2010 AGM ON 21APR11, DURING WHICH THE FOLLOWING PROPOSAL(S) WAS/WERE APPROVED:
1. 2010 WORK REPORT OF THE BOARD OF DIRECTORS
2. 2010 WORK REPORT OF THE SUPERVISORY COMMITTEE
3. 2010 FINANCIAL RESOLUTION REPORT
4. 2010 ANNUAL REPORT AND ITS SUMMARY
5. 2010 PROFIT DISTRIBUTION PLAN
6. AMENDMENTS TO THE CO'S ARTICLES OF ASSOCIATION
THE DETAILED PROFIT DISTRIBUTION PLAN ARE AS FOLLOWS:
1) CASH DIVIDEND/10 SHARES (TAX INCLUDED): CNY10.0000
2) BONUS ISSUE FROM PROFIT (SHARE/10 SHARES): NONE
3) BONUS ISSUE FROM CAPITAL RESERVE (SHARE/10 SHARES): 10.00
Date: 2011-03-23
Title: FINAL DIVIDEND
THE CO ISSUED ITS 2010 ANNUAL REPORT ON 23MAR11.

THE PROFIT DISTRIBUTION PROPOSAL FOR 2010:
1. CASH DIVIDEND/10 SHARES (TAX INCLUDED): CNY10.0000
2. BONUS ISSUE FROM PROFIT (SHARE/10 SHARES):NONE
3. BONUS ISSUE FROM CAPITAL RESERVE (SHARE/10 SHARES):10.00
Date: 2011-03-23
Title: AGM-SPOT
THE CO WILL HOLD THE 2010 AGM AT 09:00 ON 21APR11.

MEETING AGENDA:
1. 2010 WORK REPORT OF THE BOARD OF DIRECTORS
2. 2010 WORK REPORT OF THE SUPERVISORY COMMITTEE
3. 2010 FINANCIAL RESOLUTION REPORT
4. 2010 ANNUAL REPORT AND ITS SUMMARY
5. 2010 PROFIT DISTRIBUTION PLAN
6. AMENDMENTS TO THE CO'S ARTICLES OF ASSOCIATION
THE DETAILED PROFIT DISTRIBUTION PLAN ARE AS FOLLOWS:
1) CASH DIVIDEND/10 SHARES (TAX INCLUDED): CNY10.0000
2) BONUS ISSUE FROM PROFIT (SHARE/10 SHARES): NONE
3) BONUS ISSUE FROM CAPITAL RESERVE (SHARE/10 SHARES): 10.00

MEETING ATTENDEES:
1. A-SHARE HOLDERS REGISTERED AT CSDCC SZN AFTER THE CLOSE OF TRADING ON 15APR11 ARE ENTITLED TO VOTE. ORIGINAL NOTARIZED POWER OF ATTORNEY FOR VOTING IS REQUIRED.
2. DIRECTORS OF THE BOARD, SUPERVISORS OF THE SUPERVISORY COMMITTEE, SENIOR EXECUTIVES AND APPOINTED LAWYERS ARE ENTITLED TO ATTEND THE MEETING.

REGISTRATION PERIOD: 18APR11
Date: 2011-03-16
Title: EGM RESOLUTION
THE CO HELD ITS 1ST EGM OF 2011 ON 15MAR11, DURING WHICH THE FOLLOWING PROPOSAL(S) WAS/WERE APPROVED:
1. REELECTION OF MR LIU LING'AN, MR CHEN SHUIQING, MR LIU ZHENGQING, MR HE SANXING AND MR LIU HOUYAO AS DIRECTOR AND MR CAI GUANGXIAN, MR LIU ZHONGHUA, MR ZHAO DEJUN AND MS ZHAN PING AS INDEPENDENT DIRECTOR
2. REELECTION OF MS TONG XUEXI AND MR FU RENHUI AS SUPERVISOR
3. ALLOWANCE FOR INDEPENDENT DIRECTORS
4. CHANGE OF AUDIT FIRM